GSK to develop up to 12 new medicines in collaboration with Chinese firm
Total deal value up to $12 billion Hengrui Pharma shares jump 24% Complements GSK's existing pipeline GSK (GSK) has entered into an agreement with China's largest drugmaker, Hengrui Pharmaceuticals (1276:HKG), to develop a dozen...
28 July 2025